Literature DB >> 29405202

Breast cancer: Recurrent fusions in endocrine-resistant disease.

Diana Romero.   

Abstract

Entities:  

Year:  2018        PMID: 29405202     DOI: 10.1038/nrclinonc.2018.26

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Authors:  R J Hartmaier; S E Trabucco; N Priedigkeit; J H Chung; C A Parachoniak; P Vanden Borre; S Morley; M Rosenzweig; L M Gay; M E Goldberg; J Suh; S M Ali; J Ross; B Leyland-Jones; B Young; C Williams; B Park; M Tsai; B Haley; J Peguero; R D Callahan; I Sachelarie; J Cho; J M Atkinson; A Bahreini; A M Nagle; S L Puhalla; R J Watters; Z Erdogan-Yildirim; L Cao; S Oesterreich; A Mathew; P C Lucas; N E Davidson; A M Brufsky; G M Frampton; P J Stephens; J Chmielecki; A V Lee
Journal:  Ann Oncol       Date:  2018-04-01       Impact factor: 32.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.